327 related articles for article (PubMed ID: 9879409)
41. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
42. [How to manage allergic rhinitis in current practice].
Eloit C; Marmouz F
Allerg Immunol (Paris); 2001 Dec; 33(10):406-8. PubMed ID: 11802483
[TBL] [Abstract][Full Text] [Related]
43. [Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].
Xing DR; Wen TH; Yu YL; Wei ZP; Li YM; Han T
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):422-7. PubMed ID: 19288915
[TBL] [Abstract][Full Text] [Related]
44. Immunologic evaluation of 24 month course of sublingual immunotherapy.
Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S
Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022
[TBL] [Abstract][Full Text] [Related]
45. Clinical evaluation of lumiward immunoassay system for detection of specific IgE associated with allergic rhinitis.
Yamada K; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Hayashi M; Kishimoto K; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():169-77. PubMed ID: 9879417
[TBL] [Abstract][Full Text] [Related]
46. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of immunotherapy by nasal antigen challenge.
Cengizlier R; Saraçlar Y; Tomaç N
J Otolaryngol; 1999 Aug; 28(4):185-8. PubMed ID: 10461254
[TBL] [Abstract][Full Text] [Related]
48. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis.
Nishimura I; Igarashi T; Enomoto T; Dake Y; Okuno Y; Obata A
Allergol Int; 2009 Jun; 58(2):179-85. PubMed ID: 19240374
[TBL] [Abstract][Full Text] [Related]
49. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
Marogna M; Spadolini I; Massolo A
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
[TBL] [Abstract][Full Text] [Related]
50. Medical management of noninfectious rhinitis.
Hendeles L; Weinberger M; Wong L
Am J Hosp Pharm; 1980 Nov; 37(11):1496-1504. PubMed ID: 6111217
[TBL] [Abstract][Full Text] [Related]
51. [Blocking antibodies in Dermatophagoides allergy].
Sánchez Armengol A; Castillo Gómez J; Ortega Ruiz F; Segado Soriano A
Allergol Immunopathol (Madr); 1995; 23(6):271-6. PubMed ID: 8579005
[TBL] [Abstract][Full Text] [Related]
52. New treatments for allergic rhinitis.
Tkachyk SJ
Can Fam Physician; 1999 May; 45():1255-60. PubMed ID: 10349070
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of sublingual immunotherapy in Asian children.
Park IH; Hong SM; Lee HM
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336
[TBL] [Abstract][Full Text] [Related]
54. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
Du X; Shu C; Xu G; Ma M; Song H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
[TBL] [Abstract][Full Text] [Related]
55. Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone propionate and ketotifen in the treatment of 2-4-year-old children with perennial rhinitis.
Fokkens WJ; Scadding GK
Pediatr Allergy Immunol; 2004 Jun; 15(3):261-6. PubMed ID: 15209960
[TBL] [Abstract][Full Text] [Related]
56. Monoid sublingual immunotherapy.
Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
[TBL] [Abstract][Full Text] [Related]
57. Effect of allergen immunotherapy on soluble adhesion molecules.
Pereira-Santos MC; Pregal AL; Spínola-Santos A; Alonso E; Palma-Carlos ML; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Jun; 33(6):225-8. PubMed ID: 11505805
[TBL] [Abstract][Full Text] [Related]
58. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
59. Migen in the treatment of perennial rhinitis.
Cooper B
Br J Clin Pract; 1979; 33(11-12):323-4. PubMed ID: 540088
[No Abstract] [Full Text] [Related]
60. Persistent allergic rhinitis in older patients: therapies worth trying.
Klein GL
Geriatrics; 1987 Oct; 42(10):91-4. PubMed ID: 2443425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
